The WHO typing of pituitary tumors: A commentary [3]

Acta Neuropathologica

Volumn 111, Issue 1, 2006, Pages 60-61

  Farrell, W E ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; GALECTIN; GENE PRODUCT; RETINOBLASTOMA PROTEIN;

DIAGNOSTIC PROCEDURE; DISEASE MARKER; ENDOCRINE TUMOR; EPIGENETICS; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS TUMOR; LETTER; NONHUMAN; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE; WORLD HEALTH ORGANIZATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENES, NEOPLASM; GENES, TUMOR SUPPRESSOR; HUMANS; PITUITARY NEOPLASMS; PROGNOSIS; WORLD HEALTH ORGANIZATION;

EID: 29544438276     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-005-1094-5     Document Type: Letter

References (13)

1. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: A systematic review. Cancer 101:613-619 10.1002/cncr.20412
2. Al-Shraim M, Asa SL (in press) The 2004 World Health Organization classification of pituitary tumours: What is new?
3. DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Tumours of endocrine organs. World Health Organization classification of tumours. IARC, Lyon
4. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab. 84:761-767
5. Abbud RA, Takumi I, Barker EM, Ren SG, Chen DY, Wawrowsky K, Melmed S ( 2005) Early multipotential pituitary focal hyperplasia in the alpha-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol Endocrinol 19:1383-1391 10.1210/me.2004-0403
6. Leung SW, Wloga EH, Castro AF, Nguyen T, Bronson RT, Yamasaki LA (2004) A dynamic switch in Rb+/- mediated neuroendocrine tumorigenesis. Oncogene 23:3296-3307 10.1038/sj.onc.1207457
7. Zhou Z, Flesken-Nikitin A, Levine CG, Shmidt EN, Eng JP, Nikitina EY, Spencer DM, Nikitin AY (2005) Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice. Cancer Res 65:787-796 15705875
8. Buch HN, Raskauskiene D, Bahar A, Bicknell EJ, Farrell WE, Clayton RN (2004) Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis. Clin Endocrinol 61:19-25 10.1111/ j.1365-2265.2004.02046.x
9. Simpson DJ, Clayton RN, Farrell WE (2002) Preferential loss of death associated protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion. Oncogene 21:1217-1224 10.1038/sj.onc.1205195
10. Ruebel KH, Jin L, Qian X, Scheithauer BW, Kovacs K, Nakamura N, Zhang H, Raz A, Lloyd RV (2005) Effects of DNA methylation on galectin-3 expression in pituitary tumors. Cancer Res 65:1136-1140 10.1158/ 0008-5472.CAN-04-3578
11. Qian ZR, Sano T, Yoshimoto K, Yamada S, Ishizuka A, Mizusawa N, Horiguchi H, Hirokawa M, Asa SL (2005) Inactivation of RASSF1 A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas. Lab Invest 85:464-473 10.1038/labinvest.3700248
12. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A (2005) Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 90:2179-2186 10.1210/ jc.2004-1848
13. Bahar A, Simpson DJ, Cutty SJ, Bicknell JE, Hoban PR, Holley S, Mourtada-Maarabouni M, Williams GT, Clayton RN, Farrell WE (2004) Isolation and characterization of a novel pituitary tumor apoptosis gene. Mol Endocrinol 18:1827-1839 10.1210/me.2004-0087